GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Stifel 2017 Healthcare Conference on Wednesday, November 15, 2017 at 9:30 am EST. The conference is being held at the Lotte New York Palace Hotel in New York City.
A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.
About GTx
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of serious medical conditions, including treatments for stress urinary incontinence and prostate cancer.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005339/en/
Contacts:
Argot Partners
Kimberly Minarovich or Sam
Martin, 212-600-1902
or
Media:
Red House Consulting
Denise
Powell, 510-703-9491
denise@redhousecomms.com